RUO grade Nanobeads
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
L00863-1 | CytoSinct™ CD4 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00863-0.5 | CytoSinct™ CD4 Nanobeads, human | 500 uL | Up to 5×108 total cells | Quote |
L00864-1 | CytoSinct™ CD8 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00864-0.5 | CytoSinct™ CD8 Nanobeads, human | 500 uL | Up to 5×108 total cells | Quote |
L00896-1 | CytoSinct™ CD3 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00896-0.5 | CytoSinct™ CD3 Nanobeads, human | 500 uL | Up to 5×108 total cells | Quote |
L00898-1 | CytoSinct™ Streptavidin Nanobeads | 1 mL | Up to 1×109 total cells | Quote |
L00898-0.5 | CytoSinct™ Streptavidin Nanobeads | 500 uL | Up to 5×108 total cells | Quote |
L00897-1 | CytoSinct™ TCR αβ Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00897-7.5 | CytoSinct™ TCR αβ Nanobeads, human | 7.5 mL | Up to 7.5×109 total cells | Quote |
L00903-1 | CytoSinct™ CD56 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00903-0.5 | CytoSinct™ CD56 Nanobeads, human | 500 uL | Up to 5×108 total cells | Quote |
L00967-1 | CytoSinct™ CD34 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00956coming soon | CytoSinct™ CD14 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00957-1 | CytoSinct™ CD19 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00957-0.5 | CytoSinct™ CD19 Nanobeads, human | 500 μL | Up to 5×108 total cells | Quote |
L00958coming soon | CytoSinct™ CD25 Nanobeads, human | 1 mL | Up to 1×109 total cells | Quote |
L00959-1 | CytoSinct™ Anti-biotin Nanobeads | 1 mL | Up to 1×109 total cells | Quote |
L00959-0.5 | CytoSinct™ Anti-biotin Nanobeads | 500 μL | Up to 5x108 total cells | Quote |
GMP grade Nanobeads
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
L00932-7.5 | CytoSinct™ CD4 Nanobeads, human (GMP) | 7.5 mL | Up to 4×1010 total cells | Quote |
L00933-7.5 | CytoSinct™ CD8 Nanobeads, human (GMP) | 7.5 mL | Up to 4×1010 total cells | Quote |
L00934 | CytoSinct™ CD3 Nanobeads, human (GMP) | 7.5 mL | Up to 4×1010 total cells | Quote |
L00948 | CytoSinct™ CD34 Nanobeads, human (GMP) | 7.5 mL | Up to 4×1010 total cells | Quote |
L00949 | CytoSinct™ CD56 Nanobeads, human (GMP) | 7.5 mL | Up to 4×1010 total cells | Quote |
L00952 | CytoSinct™ TCR αβ Nanobeads, human (GMP) | 7.5 mL | Up to 2×1010 total cells | Quote |
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
D00006 | CytoSinct™ gStand | 1 pc | Compatible with all CytoSinct™ Magnets | Quote |
D00007 | CytoSinct™ gM columns | 25 pc | Up to 2×108 total cells (each column) | Quote |
D00008 | CytoSinct™ gL columns | 25 pc | Up to 2×109 total cells (each column) | Quote |
D00009 | CytoSinct™ M1 magnet | 1 pc | Holds 1 CytoSinct™ gM column | Quote |
D00010 | CytoSinct™ M8 magnet | 1 pc | Holds 8 CytoSinct™ gM columns | Quote |
D00011 | CytoSinct™ L1 magnet | 1 pc | Holds 1 CytoSinct™ gL column | Quote |
D00012 | CytoSinct™ L4 magnet | 1 pc | Holds 4 CytoSinct™ gL columns | Quote |
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
D00023 | CytoSinct™ 1000 | 1 unit | Compatible with CytoSinct™ 1000 tubing set products | Quote |
D00029 | CytoSinct™ 1000 Tubing Set | 1 set | Up to 6×1010 total cells | Quote |
D00030 | CytoSinct™ 1000 LS Tubing Set | 1 set | Up to 1.2×1011 total cells | Quote |
D00031 | CytoSinct™ 1000 Depletion Tubing Set | 1 set | Up to 1.2×1011 total cells | Quote |
RUO grade Activation Reagent
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
L00899-1 | Enceed™ T cell Activation, human | 1 mL | Up to 2×108 T cells | Quote |
L00899-0.5 | Enceed™ T cell Activation, human | 500 uL | Up to 1×108 T cells | Quote |
GMP grade Activation Reagent
Catalog Number | Product Name | Package Size | Capacity | Price |
---|---|---|---|---|
L00935 | Enceed™ T cell Activation, human (GMP) | 4 mL | Up to 2×108 T cells | Quote |
Multiply Labs and GenScript Collaborate to Automate the Cell Isolation for Cell Therapy Manufacturing. Learn More >>
On November 14, 2024, Base Therapeutics Co., Ltd. announced that its independently
developed, world-first base-edited universal NK cell product, NK510 Cell Injection, received
Investigational New Drug (IND) application approval from the U.S. Food and Drug Administration (FDA)
for the clinical treatment of advanced solid tumors. On October 22, NK510 Cell Injection received the
IND approval form NMPA.
GenScript is proud to have supported the development of this groundbreaking therapy with our CytoSinct™ Cell Isolation Nanobeads (GMP) and CytoSinct™ 1000 instrument.
The CytoSinct™ platform has completed FDA DMF activation, underscoring its readiness for clinical applications.
For more information, or to request a demonstration, please submit the form or email us at [email protected]
Learn more about the Cell Therapy Development Comprehensive Product Solutions.
Learn More